Zoltán Kapui

Title: Zoltán Kapui: Innovator in Pharmaceutical Chemistry

Introduction

Zoltán Kapui is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymes and receptors.

Latest Patents

Zoltán Kapui holds three patents, showcasing his innovative work. His latest patents include compounds that are heterocyclic amides useful as inhibitors of the dipeptylpeptidase-IV (DPP-IV) enzyme, along with the processes for their preparation and the intermediates involved. Another significant patent involves imidazoquinoline derivatives, which serve as adenosine A3 ligands. This invention relates to adenosine A receptor ligands of a general formula, focusing on antagonists and their various forms, including salts, solvates, and isomers.

Career Highlights

Zoltán Kapui is currently associated with Sanofi-Aventis, a leading global biopharmaceutical company. His work at Sanofi-Aventis has allowed him to further his research and development efforts in the pharmaceutical sector.

Collaborations

Throughout his career, Zoltán has collaborated with esteemed colleagues such as László Balázs and Sándor Bátori. These collaborations have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Zoltán Kapui's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of new therapeutic compounds.